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Activation of a local tissue angiotensin system in podocytes by
mechanical strain.
Background. Glomerular capillary hypertension, a common
denominator in various forms of progressive glomerular dis-
ease, results in mechanical distention of the capillary tuft, and
subsequent injury of the overlying podocyte layer. The mecha-
nisms by which elevated intraglomerular pressure is translated
into a maladaptive podocyte response remain poorly under-
stood. Angiotensin II plays a central role in the pathogenesis
of chronic renal injury, largely through its actions on the sub-
type 1 receptor. Accordingly, we have tested the hypothesis that
mechanical strain up-regulates local angiotensin II in podocytes,
thereby resulting in a progressive reduction in podocyte
number.
Methods. Conditionally immortalized mouse podocytes were
subjected to cyclical stretch of 10% amplitude. Nonstretched
podocytes served as controls. Angiotensin II levels were
measured in whole cell lysate by competitive enzyme-linked
immunosorbent assay (ELISA). Expression of angiotensin II
receptors (AT1R, AT2R) was measured by quantitative poly-
merase chain reaction (PCR) and Western blot analysis. Apop-
tosis was measured by Hoechst staining. Immunostaining for
AT1R was performed in tissue sections from rats with 5/6 rem-
nant kidney disease, a model of glomerular hypertension.
Results. Mechanical strain increased angiotensin II produc-
tion in podocytes at 24, 48, and 72 hours (P < 0.05 vs. non-
stretched controls). Stretching podocytes resulted in a fivefold
increase in AT1R mRNA expression at 24 hours and a twofold
increase in protein levels vs. controls (P < 0.05), and also an
increase in transforming growth hormone-b (TGF-b) mRNA
expression. AT1R staining was increased in a podocyte distri-
bution in the 5/6 remnant kidney, consistent with our in vitro
findings. Mechanical strain resulted in a 2.5-fold increase in
apoptosis (P <0.001 vs. nonstretched controls) in an angiotensin
II–dependent fashion.
Conclusion. Mechanical strain leads to up-regulation of the
AT1R and increased angiotensin II production in condition-
1See Editorial by Kriz, p. 333.
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ally immortalized podocytes. The resulting activation of a local
tissue angiotensin system leads to an increase in podocyte apop-
tosis, mainly in an AT1R-mediated fashion.
Podocytes are terminally differentiated epithelial cells
lining the outer aspect of glomerular capillaries. Through
an actin-based contractile apparatus, podocytes coun-
terbalance the pressure within the underlying capillary,
thereby preventing outward ballooning of the vessel and
thus, preserving the normal architecture of the glomeru-
lar tuft [1]. Podocytes are vulnerable to many forms of
injury, including both immune-mediated [2, 3] and nonim-
mune processes [4–9]. The subsequent loss of podocytes
is central to the development of glomerulosclerosis. As
glomeruli become irreversibly scarred, a decline in the
functional nephron mass ensues, such that the remain-
ing nephrons are subjected to elevated pressure gradi-
ent across the capillary wall (Pgc), which may exceed
60 mm Hg [10]. The heightened Pgc results in cellu-
lar strain [11, 12]. Therefore, independent of the nature
of the inciting event, glomerular capillary hypertension
perpetuates further damage to the podocyte and repre-
sents a final common pathway to glomerulosclerosis and
end-stage renal failure [13]. Mesangial cells respond to
mechanical stress by proliferating [14]. In contrast, we
have recently shown that mechanical strain is anti-
proliferative for podocytes [15]. The inability to effec-
tively proliferate leads to a reduction in podocyte number
(“podocytopenia”) in diabetic and nondiabetic renal
diseases.
Angiotensin II has both hemodynamic and nonhemo-
dynamic effects, and has been shown to be a critical me-
diator in progressive renal disease. Through its actions
on the relative tone of the afferent and efferent arteri-
oles, circulating angiotensin II is a critical determinant of
Pgc. Inhibiting angiotensin II production and/or receptor
binding ameliorates the loss of kidney function in chronic
diabetic and nondiabetic renal diseases characterized by
increased Pgc [16, 17]. This is likely due in part to a de-
crease in Pgc mediated by angiotensin II. However, local
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tissue production of angiotensin II also mediates disease
through a series of nonhemodynamic effects, including al-
tered proliferation, apoptosis, and cellular hypertrophy
[18]. In chronic disease states of the kidney associated
with glomerular hypertension, intrarenal angiotensin II
levels are dissociated from, and typically exceed, circulat-
ing levels [19]. That the beneficial effects of angiotensin II
blockade on ameliorating disease are greater than what
could be predicted by its hemodynamic effects alone fur-
ther supports the notion of a pathogenic role for local
production of angiotensin II [17, 20].
Recent evidence suggests that angiotensin II may have
direct biologic effects on podocytes. Angiotensin II medi-
ates rearrangement of the actin cytoskeleton and inhibit-
ing angiotensin II prevents redistribution of the structural
protein zonula occludens-1 (ZO-1) in the slit diaphragm
[21]. It has been demonstrated that in diabetic nephropa-
thy, reduced levels of nephrin are restored to normal fol-
lowing angiotensin II blockade [22]. Furthermore, foot
process broadening in experimental diabetic nephropa-
thy was attenuated with angiotensin blockade [23]. Taken
together, these findings argue that the beneficial effects
of angiotensin II blockade on reducing proteinuria and
preventing glomerulosclerosis may not simply be the con-
sequence of diminished Pgc [24] but may also be due to
direct effects on the podocyte.
Although podocyte loss is an early event in the path-
way to glomerulosclerosis, the mechanisms by which
increased Pgc is translated into maladaptive podocyte
responses remain poorly understood. Accordingly, we
have performed studies to test the hypothesis that
mechanical strain up-regulates local angiotensin II in
podocytes, thereby resulting in a progressive reduction
in podocyte number.
METHODS
Cell culture
Experiments were primarily performed utilizing early
passage (passages 6 to 11), growth-restricted, con-
ditionally immortalized mouse podocytes (gift from
Peter Mundel, M.D., Albert Einstein College of
Medicine, Bronx, N.Y.). When grown under permissive
conditions (in the presence of gamma-interferon at 33◦C),
cells proliferate and display characteristics of undiffer-
entiated podocytes [25]. However, when grown under
restrictive conditions (absence of gamma-interferon at
37◦C), proliferation is markedly reduced and cells un-
dergo cytotskeletal rearrangement with the formation
of arborizing cellular processes, resembling the morpho-
logic appearance of mature differentiated podocytes in
vivo [25]. Cells were grown on collagen type I–coated
plates in RPMI 1640 media containing 10% fetal bovine
serum (FBS) (Summit Biotechnology, Ft. Collins, CO,
USA), penicillin (100 U/mL), streptomycin (100 ug/mL),
glutamine (2 mmol/L), sodium pyruvate (1 mmol/L)
(Irvine Scientific, Santa Ana, CA, USA), HEPES buffer
(10 mmol/L) (Sigma Chemical Co., St. Louis, MO, USA),
and sodium bicarbonate (0.075%, Sigma Chemical Co.).
Cells were grown under restrictive conditions for greater
than 10 days at 37 C◦ in 95% air/5% CO2.
Additionally, for the studies of angiotensin II pro-
duction in response to cyclical strain, primary cultured
mouse podocytes were utilized as previously described
[26]. Briefly stated, glomeruli were obtained from C57/bl
mice by sieving [26] and grown on a vitrogen matrix.
Podocytes were isolated and subcultured on collagen type
I–coated plates in media containing 5% FBS, penicillin
(100 U/mL), streptomycin (100 ug/mL), and glutamine
(2 mmol/L) and grown at 37◦C in 95% air/5% CO2.
Podocyte identity was confirmed based on typical cobble-
stone appearance and positive staining for the podocyte-
specific markers synaptopodin, podocin (gifts from Peter
Mundel), and WT-1 (Santa Cruz Biotechnologies, Santa
Cruz, CA, USA), as well as the absence of mesangial and
endothelial cell markers (alpha-smooth muscle actin and
factor VIII, respectively).
Experimental design for inducing mechanical strain
of cultured podocytes
Conditionally immortalized podocytes grown under re-
strictive conditions for a minimum of 10 days were seeded
onto flexible 6-well plates coated with bovine collagen
type I (Flexcell International Corporation, Hillsborough,
NC, USA) at a density of ∼90,000 cells per well, yielding
an initial confluence of 20%. Cells were allowed to adhere
and further differentiate for 72 hours, at which time cul-
ture plates were loaded onto a computer-assisted stretch
apparatus (FlexerCell Strain Unit 3000T) as previously
reported [15]. Intermittent negative pressure was applied
to the biomembrane by a vacuum, resulting in cyclical
stretch and relaxation of the adherent cell layer. Based
on pilot studies, a regimen of 60 cycles of stretch and relax-
ation per minute with an amplitude of 10% biaxial surface
elongation was uniformly applied across the membrane.
Cells grown under identical conditions (within the same
incubator as the Strain unit), but not exposed to stretch,
served as controls.
Measuring angiotensin II levels
We were concerned that residual angiotensin II present
in FCS in the cell culture media may potentially inter-
fere with enzyme-linked immunosorbent assay (ELISA)
measurements, necessitating growth under serum-free
conditions. Because conditionally immortalized mouse
podocytes grown under restrictive conditions do not
survive under serum-free conditions, primary cultured
mouse podocytes were utilized for these experiments.
Early passage primary mouse podocytes were seeded on
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6-well collagen type I–coated flexible plates at 60,000
cells per well and allowed to adhere overnight. Cells
were then washed with Hank’s balanced salt solution
(Irvine Scientific) twice and grown in serum-free me-
dia for 48 hours. Cyclical stretch of 10% amplitude was
initiated and cells harvested at 24, 48, and 72 hours by
trypsin/collagenase digestion (37◦C for 10 minutes). Cells
were washed with ice-cold phosphate-buffered saline
(PBS) twice, centrifuged at 1400 rpm for 5 minutes at 4◦C,
and suspended in 200 uL of extraction buffer containing
20 mmol/L Tris HCl (pH = 7.40), 10 mmol/L ethylenedi-
aminetetraacetic acid (EDTA), 5 mmol/L ethylene glycol
tetraacetic acid (EGTA), and protease inhibitor cocktail
(Roche Molecular Biochemicals, Indianapolis, IN, USA).
Cells were lysed by pulse sonication on ice (12 cycles) and
centrifuged at 15,000 rpm for 10 minutes at 4◦C. Protein
concentrations were measured by BCA Protein Assay Kit
(Pierce, Rockford, IL, USA) and samples adjusted to a
final concentration of 0.5 ug/uL. Angiotensin II levels in
stretched and control podocytes were measured by com-
petitive ELISA (Peninsula Laboratories, Inc., San Carlos,
CA, USA) according to the manufacturer’s instructions.
To determine whether stretch-induced increase in
angiotensin II generation was dependent on angiotensin-
converting enzyme (ACE) activity, podocytes were in-
cubated in the presence of the ACE inhibitor captopril
(10−6 mol/L) (Sigma Chemical Co.) or vehicle for 60 min-
utes prior to the initiation of mechanical strain. Protein
harvest and measurement of angiotensin II levels were
carried out as previously outlined.
Measuring mRNA levels
Total RNA was harvested from stretched and static
cells at 18, 24, 48, and 72 hours using the Trizol method
(Sigma Chemical Co.) as previously reported [15].
Three micrograms of total RNA was reverse transcribed
into cDNA using the oligo(dT) method (Gibco BRL,
Superscript First Strand Synthesis System, Life Technolo-
gies, Inc., Rockville, MD, USA) in 20 uL reaction vol-
ume. One microliter of reaction volume was used for
conventional polymerase chain reaction (PCR) in a re-
action volume of 50 uL, containing 1.5 mmol/L MgCl2.
Each PCR cycle involved an annealing step of 1 minute,
followed by a replication step of 2 minutes. The follow-
ing primer sequences and conditions (annealing temper-
ature, cycle number) were utilized: angiotensin II type
1 receptor (AT1R): 5′-GGAAACAGCTTGGTGGTG-
3′, 3′-TTCTTCCGAATACTTTAAGTC-5′ (55◦C, ×35);
angiotensin II type 2 receptor (AT2R): 5′-TATGCTC
AGTGGTCTGCTGG-3′, 3′-CGAGGTTCCGTTCTCT
CTC T-5′ (60◦C, ×39).
To determine the effects of mechanical strain on
AT1R and AT2R mRNA expression, real-time PCR was
performed, based on a quantitative colorimetric assay as
recently described [27]. PCR conditions were 2 minutes
at 50◦C, 10 minutes at 95◦C, followed by 40 cycles at 95◦C
for 15 seconds and 60 seconds for 1 minute. A sample of
stock cDNA (synthesized from podocyte RNA as above)
was serially diluted in tenfold steps and a standard curve
generated based on threshold cycle (Ct) values using
Sequence Detector 1.7 (Applied Biosystems, Foster City,
CA, USA). Quantitification of mRNA was determined
based on Ct value, normalized to glyceraldehyde-3-
phosphate dehydrogenase (GAPDH), and expressed
as the magnitude of change relative to controls. Primer
and TaqMan probes were designed by Primer Express
1.0 (Applied Biosystems) and ordered (Invitrogen Life
Sciences, Carlsbad, CA, USA, and Synthegen, Houston,
TX, USA, respectively) with sequences as follows:
AT1R primers: 5′-CCATTGTCCACCCGATGAA-3′,
3′-ACGACCACCGGTTTCAGT-5′; AT1R probe: 5′-TC
TCGCCTCCGCCGCACG-3′; AT2R primers: 5′-CCG
AGAACAGGAAGTCAAGTCAAGTAGAAC-3′, 3′-
AGAAAACGACCAGGAAACCG-5′; AT2R probe: 5′-
AAATCTTTATACTCCACCAGCTTTCAGTGATAG
TGCC-3′.
Substitution of cDNA with water was used as a nega-
tive control to exclude contamination of reagents or the
reaction mixture with genomic DNA.
Studies have shown that transforming growth factor-
b (TGF-b) causes glomulosclerosis in many forms of
renal disease. To determine the effects of mechanical
strain on TGF-b mRNA expression, RNA’se Protection
Assay was performed as we have previously reported
per manufacturer’s instructions. A commercially avail-
able DNA template (BD Biosciences Pharmingen, San
Diego, CA, USA) for the TGF-b isoforms b1, b2, b3, and
the housekeeping gene GAPDH was used to generate a
P-32 uridine triphosphate (UTP)-labeled single-stranded
antisense mRNA probe. Following DNA’se digestion, ra-
dioactivity of the probe was quantitated by scintillation
counter (Beckman LS7500) and the probe was diluted
to target concentration. 5 ug of RNA (from stretched
and control podocytes) were hybridized with the
diluted probe overnight at 56◦C. Following RNA’se diges-
tion of single-stranded fragments, the remaining double-
stranded hybridized product was precipitated, washed,
and solubilized in loading buffer. Samples were sepa-
rated on a polyacrylamide QuickPoint gel (Novex, San
Diego, CA, USA) and quantitative analysis performed
by phosphoimaging with densitometry. Results were stan-
dardized to GAPDH and expressed as degree of change
relative to controls.
Western blot analysis
The protein levels of AT1R and AT2R were measured
in control and stretched podocytes at 18, 24, 48, and
72 hours by Western blot analysis as previously described
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[27]. Briefly, cells were washed twice with ice-cold PBS
and harvested by a trypsin and collagenase (200 U/mL)
digestion at 37◦C for 10 minutes. Cells were pelleted by
centrifugation (1400 rpm for 5 minutes at 4◦C), washed
twice with ice-cold PBS, and then suspended in lysis
buffer containing 1% Triton, 10% glycerol, 20 mmol/L
HEPES, 100 mM NaCl, and protease inhibitor cocktail
(Roche Molecular Biochemicals). Following an overnight
freeze-thaw cycle, lysates were cleared by centrifugation
at 17,000g for 10 minutes at 4◦C and protein concen-
tration determined by BCA Protein Assay Kit (Pierce)
according to the manufacturer’s directions. Reducing
buffer was added to each protein extract and samples
boiled for 5 minutes. Five micrograms of reduced protein
sample was then loaded per lane on an 8%
SDS-polyacrylamide gel and subsequently transferred
to a polyvinylidine difluoride (PVDF) membrane
(Immobilon-P) by electroblotting at 350 mA for 75 min-
utes. After blocking for 30 minutes in 5% nonfat dried
milk to reduce background, membranes were incubated
with primary antibody overnight (4◦C) as follows: AT1R
(1:200 dilution) (Santa Cruz Biotechnologies), AT2R
(1:200) (Santa Cruz Biotechnologies), tubulin (1:2000 di-
lution) (NeoMarkers, Fremont CA, USA). Incubation
of membranes with blocking peptide in tenfold excess
of primary antibody was performed as negative controls
to ensure antibody specificity. Following three wash cy-
cles with Tris-buffered saline with 0.1% Tween (TBST),
membranes were incubated with either an antimouse or
antirabbit alkaline phosphatase-conjugated secondary
antibody (1:2000 dilution) (Promega, Madison, WI,
USA) for 60 minutes at room temperature. The chro-
magen 5-bromo-4-chloro-3-inodyl phosphate/nitro blue
tetrazolium (Sigma Chemical Co.) was used for detection
of the resultant bands. Densitometric quantitation was
performed using ImagePro-Plus software (Media Cyber-
netics, Silver Spring, MD, USA) and results corrected to
tubulin levels, used as a housekeeper, to correct for any
potential errors in loading.
Tissue levels of AT1R in experimental models
of glomerular capillary hypertension
In order to ensure that the cell culture results
also occurred in vivo, the 5/6 remnant kidney disease
model of glomerular capillary hypertension [28] was
created in Sprague-Dawley rats by performing unilat-
eral nephrectomy and infarction of the upper and lower
poles of the remaining kidney through ligation of the
posterior and anterior branches of the renal arteries.
Animals were sacrificed on day 35 and the remnant kid-
ney was harvested. Biopsies were fixed in formalin and
immunstaining performed as previously described [27]
for AT1R. Tissue from age-matched sham-operated rats
served as controls. Briefly, tissue sections were deparaf-
finized in Histoclear (National Diagnostics, Atlanta, GA,
USA), rehydrated with ethanol, and treated with hydro-
gen peroxide to neutralize endogenous peroxidase. Anti-
gen retrieval was performed by boiling in citric acid for
10 minutes and background staining reduced by apply-
ing avidin-biotin blocking kit (Vector Laboratories, Inc.,
Burlingame, CA, USA) per manufacturer’s instructions.
Tissue sections were incubated with the primary AT1R
antibody overnight (1:500 dilution) (Santa Cruz Biotech-
nologies) at 4◦C, then biotinylated secondary antibody
(1:100 dilution) (Promega) for 60 minutes at room tem-
perature, followed by ABC reagent (Vector Laboratories,
Inc.) for 20 minutes at room temperature. Color devel-
opment was achieved by incubating in diaminobenzidine
(DAB) solution at 37◦C for 10 minutes and counterstain-
ing in methyl green for 2 minutes. Substitution of the
primary antibody with an irrelevant rabbit IgG served as
a negative control.
Measuring apoptosis
Apoptosis of stretched and nonstretched podocytes
was measured at 24 hours by Hoechst staining (Hoechst
33342) (Molecular Probes, Eugene, OR, USA) as
previously reported [29]. Conditionally immortalized
podocytes were grown in the presence of 1% fetal calf
serum (FCS). One millimole per liter stock of Hoescht
stain was added to each well in a 1:100 dilution 5 minutes
prior to visualization by inverted fluorescent microscopy.
Apoptosis was determined by nuclear condensation pat-
tern and expressed as the percentage of apoptotic cells
per high power field. A total of 10 high power fields in a
pericentric distribution were quantitated per well and 2
wells per experimental condition studied.
Statistical analysis
All experiments described in this manuscript were per-
formed a minimum of three times.
Statistical analysis on data obtained for angiotensin
II measurements and apoptosis was performed using
analysis of variance (ANOVA) with a Bonferroni-Dunn
correction (Statview 5.0) (Abacus Concepts, Berkeley,
CA, USA). A P value <0.05 was considered statistically
significant.
RESULTS
Mechanical strain increases angiotensin II levels
in primary cultured podocytes
Podocytes are known to possess the metabolic machin-
ery necessary for autologous synthesis of angiotensin II
[30]. Accordingly, we determined the effects of mechan-
ical strain on local angiotensin II production by cultured
podocytes, using a competitive ELISA. Primary culture
mouse podocytes were subjected to either cyclical stretch
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Fig. 1. Mechanical strain increases angiotensin II (ANG II) production
by cultured podocytes. Angiotensin II levels were measured in total cell
lysates by competitive enzyme-linked immunosorbent assay (ELISA).
Compared to nonstretched controls, stretching primary culture mouse
podocytes increased angiotensin II levels at all time points. ∗P <
0.05.
of 10% amplitude or static conditions and protein har-
vested from total cell lysate at 24, 48, and 72 hours as
outlined in the Methods section. As shown in Figure 1,
there was a threefold increase in angiotensin II levels at
24 hours under stretch conditions and these changes were
still persistent at 72 hours. Preincubation with the ACE
inhibitor captopril (10−6 mol/L) did not block the stretch-
induced increase in angiotensin II generation (data not
shown).
Conditionally immortalized podocytes express
AT1R and AT2R
We next wished to verify that conditionally immortal-
ized mouse podocytes grown under restrictive conditions
express receptors for angiotensin II. Conventional re-
verse transcription (RT)-PCR was performed to measure
the mRNA expression of AT1R and AT2R. As shown
in Figure 2, bands of 556 and 427 bp, the predicted size
for AT1R and AT2R, respectively, were detected at 40
cycles. In contrast, no product was detected under con-
trol conditions. Immunoblotting studies confirmed the
presence of AT1R and AT2R at the protein level in the
conditionally immortalized podocyte cell line (data not
shown).
Mechanical strain increases AT1R expression
The effects of mechanical strain on angiotensin II re-
ceptor expression in podocytes was determined by quan-
titating mRNA and protein levels in cells exposed to
stretch. Conditionally immortalized mouse podocytes
grown under restrictive conditions were subjected to
cyclical stretch of 10% amplitude. mRNA expression
of AT1R was measured by quantitative real-time PCR.
As shown in Figure 3, there was a fivefold increase in
AT1R mRNA levels (corrected for the housekeeping
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Fig. 2. Conditionally immortalized podocytes express receptors for an-
giotensin II. Conventional reverse transcription-polymerase chain re-
action (RT-PCR) was used to determine the mRNA expression of an-
giotensin II type 1 receptor (AT1R) and angiotensin II type 2 receptor
(AT2R) in conditionally immortalized podocytes. RNA harvested from
mouse renal cortex and mouse brain cortex was used as positive control
for AT1R and AT2R, respectively. Three micrograms of total RNA were
reverse transcribed and PCR performed as outlined in the Methods sec-
tion. At 40 cycles of amplication, specific bands were detected at 427
and 564 bp, the predicted size for AT2R and AT1R based on primer se-
quences. When cDNA was substituted with water as a negative control,
no bands were detected.
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Fig. 3. Effects of mechanical strain on angiotensin II type 1 recep-
tor (AT1R) levels in cultured podocytes. Conditionally immortalized
mouse podocytes were subjected to cyclical stretch of 10% amplitude.
AT1R mRNA was quantitated by real-time polymerase chain reac-
tion (PCR), corrected for glyceraldehyde-3-phosphate dehydrogenase
(GAPDH), and expressed as the amount of mRNA under stretched
conditions relative to nonstretched controls. Stretch resulted in a near
fivefold increase in AT1R mRNA expression at 24 hours. ∗P < 0.05.
AT1R mRNA levels normalized by 48 hours.
gene GAPDH) in stretched cells, compared to static con-
trols, at 24 hours. AT1R mRNA expression normalized
by 48 hours. Figure 4 shows the protein levels of AT1R
measured by Western blot analysis. Densitometric analy-
sis confirmed a twofold increase in AT1R protein levels at
18 to 24 hours, and the increase was sustained at 72 hours.
In contrast, cyclical strain did not alter AT2R mRNA ex-
pression or protein levels (data not shown).
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Fig. 4. Mechanical strain increases angiotensin II type 1 receptor
(AT1R) protein levels in cultured podocytes. Stretch (S) increased pro-
tein levels of AT1R measured by Western blot analysis at different time
points compared to nonstretched controls (C). When adjusted for the
housekeeping protein tubulin, densitometry analysis (lower panel) re-
vealed a 2.0-fold increase in AT1R at 18 hours, which was sustained at
72 hours in response to mechanical strain.
Podocyte AT1R levels are increased in experimental
model of glomerular capillary hypertension
We were next interested in confirming in vivo relevance
of our in vitro findings in a disease model. The 5/6 rem-
nant kidney model in the rat is known to be associated
with glomerular capillary hypertension with resultant dis-
tention of the capillary tuft and strain of the overlying
podocyte layer. Accordingly, tissue samples from day 35
remnant kidneys were obtained for AT1R immunostain-
ing. As shown in Figure 5, when compared with tissue sec-
tions obtained from sham-operated controls, there was a
significant increase in the intensity of AT1R staining in a
podocyte distribution, consistent with the findings of the
cell culture model described earlier.
Mechanical strain induces apoptosis in conditionally
immortalized podocytes
To show biologic significance of mechanical strain-
induced activation of a local angiotensin system in
podocytes, the effects of mechanical strain on apopto-
sis were investigated. Conditionally immortalized mouse
podocytes were grown under restrictive conditions in
1% FBS and subjected to cyclical stretch of 10% am-
plitude in the presence of saralasin (10−5 mol/L) (Sigma
Chemical Co.), valsartsan (10−5 mol/L) (Novartis Pharma
AG, Basel, Switzerland), or vehicle. Nonstretched cells
served as controls. As shown in Figure 6, mechanical
strain caused a 2.5-fold increase in apoptosis compared to
static controls (18.9% vs. 7.6%, respectively, P < 0.001).
Blocking angiotensin II with either a nonspecific antago-
nist of angiotensin II receptor (saralasin) or a selective
AT1R antagonist (valsartan) ameliorated the stretch-
induced increase in apoptosis (11.3% and 11.8%,
respectively, P < 0.001 vs. stretch alone), whereas stretch-
ing in the presence of vehicle did not significantly alter
the rate of apoptosis (17.9%). These results show that
stretch-induced podocyte apoptosis occurs mainly in an
AT1R-dependent fashion.
Exogenous angiotensin II induces apoptosis
in conditionally immortalized podocytes
To confirm that the observed stretch-induced increase
in apoptosis was due to activation of local angiotensin
production and not a result of low levels of FBS in the
growth media, exogenous angiotensin II was added to
cultured podocytes and apoptosis was measured. Condi-
tionally immortalized podocytes grown under restrictive
conditions were exposed to 1% FBS growth media con-
taining exogenous angiotensin II (10−6 mol/L) or vehicle
and apoptosis was measured at 24 hours. As shown in
Figure 7, exogenous angiotensin II resulted in a near nine-
fold increase in apoptosis when compared to podocytes
treated with vehicle alone (P < 0.001).
Mechanical strain upregulates TGF-b mRNA expression
in cultured podocytes
TGF-b is an important mediator of progressive re-
nal injury in disease states associated with glomerular
capillary hypertension through various mechanisms, in-
cluding extracellular matrix accumulation, cellular hy-
pertrophy, and altered proliferative capacity. TGF-b
is known to mediate many of the deleterious down-
stream effects of angiotensin II and recently has been
shown to induce podocyte apoptosis [31]. Therefore,
it is feasable that angiotensin II–induced apoptosis of
cultured podocytes may be mediated by TGF-b . Ac-
cordingly, the effects of mechanical strain on TGF-b
mRNA expression in cultured podocytes was measured
by RNA’se Protection Assay. As shown in Figure 8, cycli-
cal stretch resulted in a 29% and 39% increase in mRNA
expression of TGF-b1 and TGF-b3 isoforms, respec-
tively, at 24 hours, and these effects were sustained at
48 hours (P < 0.05 vs. nonstretched cells).
DISCUSSION
A reduction in podocyte number characterizes diabetic
and nondiabetic nephropathies associated with glomeru-
lar capillary hypertension (increased intraglomerular
pressure, Pgc), and has been causally linked to the devel-
opment of glomerulosclerosis [14]. Although podocyte
injury and loss occurs in experimental and human dis-
eases characterized by increased Pgc, the mechanisms
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Fig. 5. Podocyte immunostaining for an-
giotensin II type 1 receptor (AT1R) increases
in remnant kidney. Immunostaining was per-
formed for AT1R in control (A and B)
and remnant kidneys at day 35 (C). While
AT1R was detectable in an arteriole section
from control kidney (A, arrowhead), mini-
mal podocyte staining was noted. In contrast,
AT1R immunostaining was increased in the
remnant kidney at day 35 in a podocyte dis-
tribution (C, arrows). The absence of staining
with irrelevant rabbit IgG (not shown) con-
firms that AT1R staining is specific.
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Fig. 6. Mechanical strain induces apoptosis of cultured podocytes in an
angiotensin II (ANG II)-dependent fashion. Apoptosis was measured
by Hoechst staining, under static (A) and stretch conditions (B). The
number of apoptotic cells (arrows) were quantitated per high power
field under different experimental conditions and depicted graphically
(C). Mechanical stretch (second column) resulted in a 2.5-fold increase
in apoptosis compared to static controls (first column, P < 0.001). Block-
ing angiotensin II with 10−5 mol/L saralasin (a nonspecific antagonist
of angiotensin II receptor, third column) or 10−5 mol/L valsartan (a se-
lective AT1R antagonist, fourth column) ameliorated stretch-induced
apoptosis compared to stretch alone. #P < 0.001. In contrast, stretch-
ing podocytes in the presence of vehicle alone (fifth column) did not
significantly reduce apoptosis.
underlying these events are not well understood. In the
current study, we show that when cultured podocytes are
exposed to stretch, levels of angiotensin II and the AT1R
increase, and inhibiting this receptor significantly reduces
stretch-induced podocyte apoptosis. We also show that
immunostaining for AT1R increases in podocytes in the
remnant kidney model of increased Pgc.
Experimental and clinical studies have shown that re-
ducing angiotensin II synthesis or blocking the AT1R pro-
tects the kidney from progressive glomerulosclerosis in
diabetic and nondiabetic glomerular diseases [16, 17, 20].
Moreover, inhibiting angiotensin II and/or the AT1R sig-
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Fig. 7. Exogenous angiotensin II increases apoptosis of cultured
podocytes. Conditionally immortalized mouse podocytes grown in 1%
fetal bovine serum (FBS) were exposed to exogenous angiotensin
II (10−6 mol/L) or vehicle. Apoptosis was measured at 24 hours by
Hoechst staining. Angiotensin II increased podocyte apoptosis 8.5-fold
compared to podocytes treated with vehicle alone (5.1% vs. 0.6%, re-
spectively, P < 0.001).
nificantly reduces proteinuria. Studies have shown that
proteinuria characterizes injury to podocytes. However,
it is not clear why podocytes are injured when Pgc in-
creases. In the current study, we exposed cultured murine
podocytes to mechanical stretch, an in vitro model that
we [15] have utilized to delineate the mechanisms of
podocyte injury when Pgc increases. Using the same
model, Endlich et al [32] provided direct evidence that
cultured podocytes exposed to mechanical stretch indeed
are mechanosensitive, as evidenced by reorganization of
the actin cytoskeleton in response to cyclical stretch.
The major finding in the current study was that expos-
ing cultured podocytes to mechanical stretch caused a
significant increase in the tissue levels of angiotensin II
and its receptor, AT1R. Both the mRNA expression and
protein levels of the AT1R were increased in stretched
podocytes. In contrast, levels of AT2R were unaffected
by stretch. The increase in AT1R was not restricted to
only podocytes in culture, as we were able to demon-
strate an increase in AT1R immunostaining specifically in
podocytes in the experimental remnant kidney model of
glomerular capillary hypertension. This model has been
shown to result in podocyte injury.
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Fig. 8. Mechanical strain increases transforming growth factor-b
(TGF-b1) and TGF-b3 mRNA expression by cultured podocytes.
RNA’se Protection Assay was used to measure TGF-b mRNA ex-
pression and results adjusted for housekeeping gene glyeraldehyde-
3-phosphate dehydrogenase (GAPDH). Cyclical stretch increased
mRNA expression of TGF-b1 and TGF-b3 isoforms by 29% and
39%, respectively, in cultured podocytes by 24 hours compared to
static controls. ∗P < 0.05. In contrast, TGF-b2 mRNA levels remained
unchanged.
Why focus on local angiotensin II and AT1R in
podocytes? Angiotensin II is an octapeptide, which is
generated from proteolytic cleavage of the decapeptide
angiotensin I. Conversion of the inactive angiotensin I
to the active angiotensin II may occur by various enzyme
pathways, of which the ACE (made principally within the
endothelial bed of the lung) is most important in the cir-
culating pool. Under physiologic conditions, circulatory
angiotensin II mediates vasoconstriction, sodium reab-
sorption, and aldosterone production [33]. Through its
actions on the relative tone of the afferent and effer-
ent arterioles, angiotensin II is also a critical determi-
nant of glomerular capillary pressures. Reducing Pgc by
inhibiting angiotensin II with an ACE-inhibitors and/or
angiotensin receptor blockers protects the kidney from
progressive glomerulosclerosis [16]. However, there is
abundant evidence that local tissue production of an-
giotensin II also plays a critical role in mediating disease
through a series of nonhemodynamic effects, including
apoptosis, matrix accumulation, and aberrant prolifera-
tion [18]. In the present study, blocking ACE with the
ACE inhibitor captopril did not abrogate the stretch-
induced increase in angiotensin II generation. These re-
sults suggest that primarily non-ACE pathways may be
involved in cleavage of angiotensin I into angiotensin II,
consistent with what has been reported in the local pro-
duction of angiotensin II in other tissue systems including
ventricular myocytes [34, 35].
Studies have shown that the AT1R is the predominant
subtype in the kidney (>90%) and mediates both hemo-
dynamic and nonhemodynamic effects of angiotensin II,
including vasoconstriction, fibrosis, cellular hypertrophy,
and a decrease in proliferation [36, 37]. Selective block-
ade of the AT1R has proven as effective as ACE inhibitors
in retarding the progression of renal disease [38]. In con-
trast, AT2R expression is much higher during embryogen-
esis, present only in low levels in the healthy adult kidney.
The physiologic effects of AT2R largely counteract those
of the AT1R and include vasodilatation, natriuresis, and
cell differentiation [36, 39].
Thus, to understand the potential role of increased an-
giotensin II and the AT1R in stretched podocytes, we
studied the effects of AT1R inhibition, with either a
nonselective (saralasin) or selective angiotensin recep-
tor blocker (valsartan), on podocyte apoptosis. Apoptosis
has been shown by Schiffer et al [40] to reduce podocyte
number, thereby contributing to glomerulosclerosis. Our
results showed that blocking the effects of angiotensin II
significantly reduced stretch-induced apoptosis. A causal
role for stretch-induced activation of a local angiotensin
system in mediating apoptosis was further supported by
the demonstration that the addition of exogenous an-
giotensin II to cultured podocytes was likewise able to
induce apoptosis. The fact that saralasin and valsartan
were equally efficacious suggests that apoptosis is occur-
ring in an AT1R-dependent fashion. Indeed, studies by
Ding et al [41] have also shown that angiotensin II in-
duces apoptosis in cultured podocytes, and that this is
largely mediated in an AT1R-dependent fashion.
TGF-b mediates a number of the downstream non-
hemodynamic effects of angiotensin II as they relate
to progressive tissue injury and scarring, and has re-
cently been shown to play a role in mediating podocyte
apoptosis. Therefore, the demonstration that mechanical
strain also up-regulated mRNA expression of TGF-b1
and TGF-b3 may provide some clues into the mecha-
nisms by which angiotensin II mediates podocyte apopto-
sis. However, angiotensin II blockade did not completely
restore apoptosis rates to baseline, suggesting that me-
chanical strain may also be causing apoptosis through
non-angiotensin II dependent pathways.
It should be noted that the demonstration in the
present study of apoptosis resulting from mechanical
strain is in contrast to what we have previously re-
ported [15]. However, a number of differences exist in
the current experimental design that may account for
these findings. First, we used conditionally immortalized
murine podocytes grown under restrictive conditions in
the current study, whereas we used proliferating primary
culture mouse podocytes in our prior studies. Second, the
presence of survival factors in serum in our prior studies
(conducted in 5% FCS) may have blunted a proapop-
totic effect of stretch. Finally, the magnitude of stretch
was greater in the current studies. Perfusion studies per-
formed in isolated glomeruli have demonstrated that
38 Durvasula et al: Mechanical strain and the angiotensin system in podocytes
glomerular volume increases approximately 16% in re-
sponse to capillary hypertension in disease [42]. If one
views the glomerulus as a simple sphere whose volume
can be approximated by the equation 4/3 · Pi · r3, and
glomerular volume is increased by 16% in situations of
increased Pgc, then surface area of this “sphere” (as mea-
sured by the equation 4 · Pi · r2) is increased ∼10.4%.
Based on these assumptions, our choice of 10% mechan-
ical stretch for the current studies is justified and we be-
lieve approximates conditions in the in vivo setting.
Angiotensin II has been shown to have a number
of other effects on podocytes. Angiotensin II mediates
rearrangement of the actin cytoskeleton and inhibiting
angiotensin II prevents redistribution of the structural
protein ZO-1 in the slit diaphragm [21]. It has been
demonstrated that in diabetic nephropathy, levels of
nephrin in podocytes are reduced, but can be restored to
normal following angiotensin II blockade [22]. Further-
more, foot process broadening in experimental diabetic
nephropathy was attenuated with angiotensin blockade
[23]. Angiotensin II also activated specific podocyte sig-
naling [43]. Taken together, these findings argue that the
beneficial effects of angiotensin II blockade on reduc-
ing proteinuria and preventing glomerulosclerosis may
not simply be the consequence of diminished glomeru-
lar capillary pressure [24], but may also be due to direct
effects on podocytes.
CONCLUSION
We have demonstrated that mechanical strain, the
result of glomerular capillary hypertension, leads to
up-regulation of the AT1R as well as increased produc-
tion of the ligand angiotensin II in podocytes. The re-
sulting activation of a local tissue angiotensin system
leads to an increase in podocyte apoptosis, mainly in
an AT1R-mediated fashion. The clinical consequences
of stretch-induced apoptosis may include progressive
podocyte loss and glomerulosclerosis in diseases associ-
ated with glomerular capillary hypertension.
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